199 related articles for article (PubMed ID: 9163103)
1. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
2. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
Kremenetskaya OS; Logacheva NP; Baryshnikov AY; Chumakov PM; Kopnin BP
Oncol Res; 1997; 9(4):155-66. PubMed ID: 9268986
[TBL] [Abstract][Full Text] [Related]
3. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
Ehinger M; Nilsson E; Persson AM; Olsson I; Gullberg U
Cell Growth Differ; 1995 Jan; 6(1):9-17. PubMed ID: 7718488
[TBL] [Abstract][Full Text] [Related]
5. Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation.
Bi S; Barton CM; Lemoine NR; Cross NC; Goldman JM
Exp Hematol; 1994 Jan; 22(1):95-9. PubMed ID: 8282066
[TBL] [Abstract][Full Text] [Related]
6. The abnormal p53 proteins expressed in CML cell lines are non-functional.
Bi S; Lanza F; Goldman JM
Leukemia; 1993 Nov; 7(11):1840-5. PubMed ID: 8231251
[TBL] [Abstract][Full Text] [Related]
7. [Stimulation of differentiation of LIM 1215 large intestinal tumor cells during expression of the p53 exogenous antioncogene or the activated ras oncogene].
Raĭkhlin NT; Volodina IuL; Smirnova EA; Perevoshchikov AG; Chumakov PM; Kopnin BP
Arkh Patol; 1995; 57(5):34-8. PubMed ID: 8579493
[TBL] [Abstract][Full Text] [Related]
8. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP
Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331
[TBL] [Abstract][Full Text] [Related]
9. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
[TBL] [Abstract][Full Text] [Related]
10. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
[TBL] [Abstract][Full Text] [Related]
11. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
[TBL] [Abstract][Full Text] [Related]
13. Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation.
Pierce A; Spooncer E; Wooley S; Dive C; Francis JM; Miyan J; Owen-Lynch PJ; Dexter TM; Whetton AD
Oncogene; 2000 Nov; 19(48):5487-97. PubMed ID: 11114726
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
15. Expression of the normal p53 gene induces differentiation of K562 cells.
Feinstein E; Gale RP; Reed J; Canaani E
Oncogene; 1992 Sep; 7(9):1853-7. PubMed ID: 1501893
[TBL] [Abstract][Full Text] [Related]
16. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
17. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
Brusa G; Benvenuti M; Mazzacurati L; Mancini M; Pattacini L; Martinelli G; Barbieri E; Greenberger JS; Baccarani M; Santucci MA
Haematologica; 2003 Jun; 88(6):622-30. PubMed ID: 12801837
[TBL] [Abstract][Full Text] [Related]
18. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
19. Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells.
Lang D; Miknyoczki SJ; Huang L; Ruggeri BA
Oncogene; 1998 Mar; 16(12):1593-602. PubMed ID: 9569027
[TBL] [Abstract][Full Text] [Related]
20. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
